Ross G. Bentley
Ross G. Bentley publishes mostly in Molecular Biology, Cardiology and Cardiovascular Medicine and Hematology, on topics such as Blood Coagulation and Thrombosis Mechanisms, Phosphodiesterase function and regulation and Atrial Fibrillation Management and Outcomes.
- World rank
- #2,734,498 of 7,710,434 ranked researchers
- Rank in United States
- #796,238 of 1,627,098
- Works
- 45
- Citations
- 1.7k
- Citations per work
- 38.8
What does Ross G. Bentley research?
Ross G. Bentley's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (27%), Chemistry (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1942.4%
- Medicine1942.4%
- Life Sciences1227.3%
- Everything else1225.8%
- Physical Sciences24.5%
- Chemistry24.5%
- 1Molecular Biology27% of their works
- 2Cardiology and Cardiovascular Medicine20% of their works
- 3Hematology13% of their works
- 4Internal Medicine5% of their works
- 5Genetics4% of their works
- 6Organic Chemistry4% of their works
Research topics
- Blood Coagulation and Thrombosis Mechanisms
- Phosphodiesterase function and regulation
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Acute Myocardial Infarction Research
- Nitric Oxide and Endothelin Effects
- Ion channel regulation and function
Which keywords describe Ross G. Bentley's research?
The keywords of their largest research topics: Antithrombotic Therapy, Inflammation, Protease-Activated Receptors, Thrombin, Guidelines, cAMP Signaling, Cyclic Nucleotide Phosphodiesterases and Anticoagulant Therapy.
- Ion Channels
- Myocardial Infarction
- Acute Coronary Syndromes
- Hereditary Angioedema
- Pulmonary Embolism
- Anticoagulant Therapy
- Cyclic Nucleotide Phosphodiesterases
- Thrombin
- Inflammation
- Antithrombotic Therapy
- Protease-Activated Receptors
- Guidelines
- cAMP Signaling
- Atrial Fibrillation
- Venous Thromboembolism
- Kinin Receptor Family
- Endothelial Dysfunction
- Nitric Oxide
- Voltage-Gated Channels
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Antithrombotic Therapy212 topics
- Inflammation192 topics
- Protease-Activated Receptors141 topic
- Thrombin141 topic
- Guidelines132 topics
- Cyclic Nucleotide Phosphodiesterases101 topic
- cAMP Signaling101 topic
- Anticoagulant Therapy81 topic
- Atrial Fibrillation81 topic
- Pulmonary Embolism71 topic
- Venous Thromboembolism71 topic
- Hereditary Angioedema61 topic
- Kinin Receptor Family61 topic
- Acute Coronary Syndromes51 topic
- Endothelial Dysfunction51 topic
- Myocardial Infarction51 topic
- Nitric Oxide51 topic
- Ion Channels41 topic
- Voltage-Gated Channels41 topic
Where does Ross G. Bentley work?
Ross G. Bentley's main affiliation in the publication record is Sterling Research Group (United States), United States.
How many publications and citations does Ross G. Bentley have?
OpenAlex counts 45 works and 1,747 citations for Ross G. Bentley, an h-index of 23, ranking #2,734,498 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ross G. Bentley. Posts are plain text and can be reported.